JPS58225074A - ジベンゾオキサゼピン誘導体 - Google Patents

ジベンゾオキサゼピン誘導体

Info

Publication number
JPS58225074A
JPS58225074A JP10851682A JP10851682A JPS58225074A JP S58225074 A JPS58225074 A JP S58225074A JP 10851682 A JP10851682 A JP 10851682A JP 10851682 A JP10851682 A JP 10851682A JP S58225074 A JPS58225074 A JP S58225074A
Authority
JP
Japan
Prior art keywords
formula
compound
group
lower alkyl
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10851682A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0359068B2 (https=
Inventor
Kiyohiko Ito
伊東　清彦
Masuo Koizumi
小泉　益男
Yasushi Murakami
泰 村上
Hidekazu Hoshino
英一 星野
Tamotsu Yamazaki
保 山崎
Kazunari Sakai
境　一成
Shunichi Hata
畑　俊一
Yoshio Takagaki
高垣　善男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP10851682A priority Critical patent/JPS58225074A/ja
Publication of JPS58225074A publication Critical patent/JPS58225074A/ja
Publication of JPH0359068B2 publication Critical patent/JPH0359068B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP10851682A 1982-06-25 1982-06-25 ジベンゾオキサゼピン誘導体 Granted JPS58225074A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP10851682A JPS58225074A (ja) 1982-06-25 1982-06-25 ジベンゾオキサゼピン誘導体

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10851682A JPS58225074A (ja) 1982-06-25 1982-06-25 ジベンゾオキサゼピン誘導体

Publications (2)

Publication Number Publication Date
JPS58225074A true JPS58225074A (ja) 1983-12-27
JPH0359068B2 JPH0359068B2 (https=) 1991-09-09

Family

ID=14486768

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10851682A Granted JPS58225074A (ja) 1982-06-25 1982-06-25 ジベンゾオキサゼピン誘導体

Country Status (1)

Country Link
JP (1) JPS58225074A (https=)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10183936B2 (en) 2014-03-13 2019-01-22 Indiana University Research And Technology Corporation Hepatitis B core protein allosteric modulators
US10377748B2 (en) 2015-09-15 2019-08-13 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US10987360B2 (en) 2016-09-15 2021-04-27 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US11040965B2 (en) 2017-03-13 2021-06-22 Assembly Biosciences, Inc. Process for making Hepatitis B core protein modulators
US11078170B2 (en) 2017-03-02 2021-08-03 Assembly Biosciences, Inc. Cyclic sulfamide compounds and methods of using same
US11649218B2 (en) * 2018-03-09 2023-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10947224B2 (en) 2014-03-13 2021-03-16 Indiana University Research And Technology Corporation Hepatitis B core protein allosteric modulators
AU2015229174B2 (en) * 2014-03-13 2019-04-11 Assembly Biosciences, Inc. Hepatitis B core protein allosteric modulators
US10183936B2 (en) 2014-03-13 2019-01-22 Indiana University Research And Technology Corporation Hepatitis B core protein allosteric modulators
US10968211B2 (en) 2015-09-15 2021-04-06 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US10766890B2 (en) 2015-09-15 2020-09-08 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US10392379B2 (en) 2015-09-15 2019-08-27 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US10377748B2 (en) 2015-09-15 2019-08-13 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US11814376B2 (en) 2015-09-15 2023-11-14 Assembly Biosciences, Inc. Hepatitis b core protein modulators
US10987360B2 (en) 2016-09-15 2021-04-27 Assembly Biosciences, Inc. Hepatitis B core protein modulators
US11078170B2 (en) 2017-03-02 2021-08-03 Assembly Biosciences, Inc. Cyclic sulfamide compounds and methods of using same
US11040965B2 (en) 2017-03-13 2021-06-22 Assembly Biosciences, Inc. Process for making Hepatitis B core protein modulators
US11649218B2 (en) * 2018-03-09 2023-05-16 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services C-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same
US12435047B2 (en) 2018-03-09 2025-10-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services c-Abl tyrosine kinase inhibitory compound embodiments and methods of making and using the same

Also Published As

Publication number Publication date
JPH0359068B2 (https=) 1991-09-09

Similar Documents

Publication Publication Date Title
CA1334972C (en) Pyridine-2,4- and -2,5-dicarboxylic acid amides, processes for their preparation, the use thereof, and medicaments based on these compounds
EP0249950B1 (en) Aromatic compounds
JPH01211567A (ja) 新規なスルホンアミド化合物
SE500849C2 (sv) Nya 3-amino-2-oxo-azetidin-1-sulfonsyror, mellanprodukter till motsvarande 3-aminosubstituerade-2-oxo-azetidin-1-sulfonsyror
JPS58225074A (ja) ジベンゾオキサゼピン誘導体
US3751447A (en) Novel guanidinocaproic acid phenyl esters and their production
CN114181168B (zh) 一种制备n-（取代基）-2-取代基苯并噻嗪-4-酮的方法
HU182257B (en) Process for producing benzothiazole derivatives and pharmaceutical compositions containing them as active agents
SU505369A3 (ru) Способ получени эфиров 1-имидазолилметанфосфоновой кислоты
US3875173A (en) Method for introducing halogen into benzimidazole and imidazopyridine compounds
JP2003528105A (ja) 新規チアゾール化合物を用いたセファロスポリン系抗生物質の製造方法
US3542779A (en) New 4-quinazolone derivatives and process for the preparation thereof
JPS6047264B2 (ja) チアゾリジン誘導体
KR960022468A (ko) 클로로메틸피리딘의 제조방법
ISODA et al. Medicinal chemical studies on antiplasmin drugs. VI. Aza analogs of 4-aminomethylbenzoic acid
JPS6052158B2 (ja) セフアロスポリン化合物
JPS58225073A (ja) ジベンゾオキサゼピノン誘導体
KR790001687B1 (ko) 피리딘 유도체의 제법
JPS606954B2 (ja) １―（２―テトラハイドロフリル）―３―置換―５―フルオロウラシルの製造法
US3164613A (en) Hydroxybenzothiazoles and methods of preparing same
JPS5810379B2 (ja) ジペプチドルイノセイホウ
SU471715A3 (ru) Способ получени -(аминофенил)алифатических карбоновых кислот или их солей
JPS61180751A (ja) β−（アセチルアミノ）アクリル酸エステル
PL174822B1 (pl) Sposób wytwarzania kwasu [2-(2,6-dichloroanilino)fenylo] acetoksyoctowego
JPS6129949B2 (https=)